Medi Caps Quarterly Results for Trading Insights
Latest Quarter Net Profit
₹3 Cr
QMar 2026
In Mar 2026, Medi Caps (MEDICAPQ) reported revenue ₹9 Cr and net profit ₹3 Cr. Browse MEDICAPQ cash flow statement for revenue, profit, balance sheet and cash flow data.
MEDICAPQ Quarterly Results — Revenue, Profit & EPS Highlights
Medi Caps latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Medi Caps share price today.
- Revenue of ₹9 Cr in Mar 2026 (+125.0% vs Sept 2025, +0.0% vs Mar 2025)
- Net Profit of ₹3 Cr in Mar 2026 (+250.0% vs Sept 2025, +50.0% vs Mar 2025)
- EBITDA of ₹4 Cr in Mar 2026 (+500.0% vs Sept 2025)
- Operating Margin of -61.0% in Mar 2026 (+84.0pp vs Sept 2025)
- Earnings Per Share of ₹2.44 in Mar 2026 (+267.1% vs Sept 2025)
Medi Caps Quarterly Results — Revenue, EBITDA, Net Profit & EPS
MEDICAPQ quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 9 | 4 | 9 | 3 | 5 | 125.0% | - |
| Net Profit (₹ Cr) | 3 | -2 | 2 | -4 | -1 | - | - |
| EBITDA (₹ Cr) | 4 | -1 | 2 | -3 | 0 | - | - |
| EPS (₹) | 2.44 | -1.46 | 1.38 | -2.80 | -0.61 | - | - |
| Operating Margin (%) | -61.0% | -145.0% | -4.0% | -126.0% | -25.0% | - | - |
MEDICAPQ Share Price Trend — 1-Year Movement Across Quarterly Results
Medi Caps 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore MEDICAPQ share price data to track price trends across different timeframes.
Revenue Trend (₹ Cr)
Jun 2025
3
Mar 2025
9
Sept 2025
4
Mar 2026
9
Net Profit Trend (₹ Cr)
Jun 2025
-4
Mar 2025
2
Sept 2025
-2
Mar 2026
3
Operating Margin Trend (%)
Jun 2025
-126.0%
Mar 2025
-4.0%
Sept 2025
-145.0%
Mar 2026
-61.0%
MEDICAPQ vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Medi Caps latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹454,122.13 Cr | 1904.8 | 15,018 | 2,710 | +1.0% | +11.8% | 18.0% | 168.6 |
|
Divis Laboratories
Mar 2026 |
₹174,081.02 Cr | 6757.0 | 2,986 | 751 | +4.4% | +11.8% | 25.2% | 238.7 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹161,380.94 Cr | 4768.3 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 414.3 |
|
Cipla
Mar 2026 |
₹117,800.00 Cr | 1458.2 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 212.3 |
|
Dr Reddys Laborator…
Mar 2026 |
₹114,691.88 Cr | 1374.1 | 7,996 | 221 | -12.5% | -11.5% | 2.8% | 518.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores